Computational Systems Biology Perspective on Tuberculosis in Big Data Era: Challenges and Future Goals

  title={Computational Systems Biology Perspective on Tuberculosis in Big Data Era: Challenges and Future Goals},
  author={Amandeep Kaur Kahlon and Ashok Sharma},
The major concern in this chapter is to understand the need of system biology in prediction models in studying tuberculosis infection in the big data era. The overall complexity of biological phenomenon, such as biochemical, biophysical, and other molecular processes, within pathogen as well as their interaction with host is studied through system biology approaches. First, consideration is given to the necessity of prediction models integrating system biology approaches and later on for their… 
1 Citations
Screening of Anti-mycobacterial Phytochemical Compounds for Potential Inhibitors against Mycobacterium Tuberculosis Isocitrate Lyase.
Phytochemical based anti-mycobacterial compound can further developed into effective drugs against persistence tuberculosis with lesser toxicity and side effects.


Systems biology in drug discovery
Automation of complex primary human cell–based assay systems designed to capture emergent properties can now integrate a broad range of disease-relevant human biology into the drug discovery process, informing target and compound validation, lead optimization, and clinical indication selection.
The Mycobacterium tuberculosis Drugome and Its Polypharmacological Implications
We report a computational approach that integrates structural bioinformatics, molecular modelling and systems biology to construct a drug-target network on a structural proteome-wide scale. The
Systems biology of persistent infection: tuberculosis as a case study
In this article, Mycobacterium tuberculosis is used as an example of how systems-biology approaches have begun to make strides in uncovering important facets of the host–pathogen interaction.
The Past and Future of Tuberculosis Research
It is argued here, however, that new multidisciplinary approaches—especially the integration of epidemiology with systems biology in what is called “systems epidemiology”—will be required to eliminate TB.
Systems Biology and P4 Medicine: Past, Present, and Future
  • L. Hood
  • Medicine
    Rambam Maimonides medical journal
  • 2013
The convergence of patient-activated social networks, big data and their analytics, and systems medicine has led to a P4 medicine that is predictive, preventive, personalized, and participatory, thus optimizing the wellness of individuals and avoiding disease.
Big data challenges and opportunities in high-throughput sequencing
The role of big data in genomics is reviewed, its impact on the development of tools for collaborative analysis of genomes, and successes and ongoing challenges in coping with big data are reviewed.
targetTB: A target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysis
A comprehensive in silico target identification pipeline, targetTB, for Mycobacterium tuberculosis, which provides rational schema for drug target identification that are likely to have high rates of success, which is expected to save enormous amounts of money, resources and time in the drug discovery process.
A Model to Predict Cell-Mediated Immune Regulatory Mechanisms During Human Infection with Mycobacterium tuberculosis1
A virtual human model is developed that qualitatively and quantitatively characterizes the cellular and cytokine control network operational during TB infection and indicates that even if latency is achieved, it may come at the expense of tissue damage if the response is not properly regulated.
Insight into human alveolar macrophage and M. tuberculosis interactions via metabolic reconstructions
Integrated host–pathogen reconstructions form a foundation upon which understanding the biology and pathophysiology of infections can be developed and are able to describe three distinct pathological states.